Abstract
A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
B L Robbins, M C Connelly, D R Marshall, R V Srinivas and A Fridland
Molecular Pharmacology February 1995, 47 (2) 391-397;